Open access
Jul 2026
Unveiling the structural insights and inhibitory potential of coumarin-1,2,3-triazole hybrids against BACE1: a promising approach for Alzheimer’s disease therapy
Overall, the findings suggest CUM-0199 as a potential lead candidate for AD therapy, warranting further experimental validation and clinical investigation.
M. Almostafa, Iqra Ali, Galal Yahya et al.
· Frontiers in Chemistry · 0 citations